Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical data.Victor F. Huckell, A Wielgosz, S. Isserow et al.|PubMed|1997Cited by 4
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.Shaun G. Goodman, A. Langer, CA Hill et al.|PubMed|1996Cited by 3
Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.Victor F. Huckell, Andreas Wielgosz, Victoria Bernstein et al.|PubMed|1997Cited by 3